Diametric Capital »

Adagio Therapeutics shares owned by Diametric Capital

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Diametric Capital from 13F filings

Historical chart of Diametric Capital investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Diametric Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Diametric Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $114k 88k 1.30

More positions owned by Diametric Capital

Precigen (PGEN)
Bitmine Immersion Tecnologie Com New (BMNR)
Janone (ALTS)
Liquidia Corporation Com New (LQDA)
Fulgent Genetics (FLGT)
Golar Lng SHS (GLNG)
Penn National Gaming (PENN)
Wynn Resorts (WYNN)
Brinker International (EAT)
Forgent Power Solutions Com Shs Cl A (FPS)
Asp Isotopes (ASPI)
Telephone & Data Sys Com New (TDS)
Harrow Health (HROW)
Eton Pharmaceuticals (ETON)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Diametric Capital

Top funds holding Adagio Therapeutics

Henderson Group
Perceptive Advisors
BVF
Maverick Capital
Driehaus Capital Management
Vanguard Group
Vanguard Capital Management
M28 Capital Management
Saturn V Capital Management
Soleus Capital Management
Eventide Asset Management
State Street Corporation
BlackRock
Siren
ADAR1 Capital Management

View all funds holding Adagio Therapeutics